Additional Upfront Payment Under Licensing Arrangement

No definition available.

Name:	scyx_AdditionalUpfrontPaymentUnderLicensingArrangement
Namespace Prefix:	scyx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Collaborative Arrangement, Development Milestone Proceeds

+ References

No definition available.

+ Details

Name:	scyx_CollaborativeArrangementDevelopmentMilestoneProceeds
Namespace Prefix:	scyx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Deferred revenue recognition period.

+ References

No definition available.

+ Details

Name:	scyx_DeferredRevenueRecognitionPeriod
Namespace Prefix:	scyx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of Compounds

+ References

No definition available.

+ Details

Name:	scyx_NumberofCompounds
Namespace Prefix:	scyx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Option Exercise Period For Additional Compounds Under License Agreement

+ References

No definition available.

+ Details

Name:	scyx_OptionExercisePeriodForAdditionalCompoundsUnderLicenseAgreement
Namespace Prefix:	scyx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Research and Development Arrangement, Commitment to Services Agreement, Term

+ References

No definition available.

+ Details

Name:	scyx_ResearchandDevelopmentArrangementCommitmenttoServicesAgreementTerm
Namespace Prefix:	scyx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Research and Development Arrangement, Contract to Perform for Others, Maximum Net Sales Target Proceeds

+ References

No definition available.

+ Details

Name:	scyx_ResearchandDevelopmentArrangementContracttoPerformforOthersMaximumNetSalesTargetProceeds
Namespace Prefix:	scyx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Upfront Payment Under License Agreement

+ References

No definition available.

+ Details

Name:	scyx_UpfrontPaymentUnderLicenseAgreement
Namespace Prefix:	scyx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_LicensesRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Cash received from collaborators during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromCollaborators
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=scyx_WaterstoneLicensingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=scyx_RPharmCollaborationArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Significant Agreements (Details) $ in Millions		1 Months Ended		12 Months Ended
Significant Agreements (Details) $ in Millions	Oct. 29, 2014 compound	Nov. 30, 2014 USD ($)	Aug. 31, 2013 USD ($)	Dec. 31, 2014 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Deferred revenue recognition period (in months)			70 months
Number of compounds \| compound	2
Waterstone Licensing Agreement \| Licensing Agreement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Milestone payment for first product registration		$ 4.0
Option exercise period	18 months
Contract term	10 years
Upfront payment		1.0
Additional upfront payment		$ 0.5
Revenue from non-refundable upfront payment				$ 1.0
Development, License, and Supply Agreement \| R-Pharm Collaboration Arrangement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Proceeds from collaborators			$ 1.5
Milestone payment for first product registration			3.0
Sales based payments			$ 15.0
Deferred revenue recognition period (in months)			70 months